title: PCSK9 inhibition and the global diabetes epidemic.
authors.affiliation: Comando Brigata Alpina "Julia"/Multinational Land Force, Medical Service, 8 Via S. Agostino, Udine, 33100, Italy. lumasci@libero.it.
authors.forename: Luca
authors.initials: L
authors.lastname: Mascitelli
authors.affiliation: NCH Physician Group, Naples, FL, USA.
authors.forename: Mark R
authors.initials: MR
authors.lastname: Goldstein
mesh_terms: D000911:Antibodies, Monoclonal; D000924:Anticholesteremic Agents; D002318:Cardiovascular Diseases; D008078:Cholesterol, LDL; D003920:Diabetes Mellitus; D006801:Humans; D000071449:Proprotein Convertase 9
chemical_list: D000911:Antibodies, Monoclonal; D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9
keywords: Cardiovascular disease; Diabetes risk; Epidemiology; Monoclonal antibody; PCSK9